Nova Scotians are being invited to help develop a tribute to Viola Desmond that will represent her legacy, and last beyond this year’s celebration. Nova Scotia’s first Heritage Day will be held Monday, Feb. 16, and will honour Ms. Desmond, the African Nova Scotian businesswoman who was wrongfully jailed and fined in 1946 for refusing to give up her seat in the segregated section of a New Glasgow movie theatre. The Remembering Viola Community Engagement Forum will be hosted by the North Branch Business Association on Monday, from 10 a.m. until 2 p.m., at the Halifax North Memorial Public Library, 2285 Gottingen St. “Viola is an icon for social justice. She is one of our Nova Scotia heroes, and deserves this kind of recognition,” said Communities, Culture and Heritage Minister Tony Ince. “The results of the workshop will be another way we are celebrating and remembering the inspiring story of Viola Desmond.” Deputy Premier Diana Whalen and Mr. Ince will join Ms. Desmond’s sister, Wanda Robson, and community members to brainstorm a tribute that will be installed this spring in north end Halifax, where Ms. Desmond lived and worked. “The North End Business Association is thrilled to be able to help facilitate the creation of a permanent memorial for Viola along Gottingen Street,” said executive director Patricia Cuttell Busby. “It is important that we recognize and celebrate members of our community who make a difference. This is an exciting project, and we look forward to collaborating with local organizations to make it a reality.” The We Heart Viola Youth Art Project, a collaboration between professional artists, youth artists and entrepreneurs from Halifax’s Gottingen Street, will also be revealed at the forum. “The project used a shared passion for art to forge new relationships and support a more cohesive community,” said Ann Denny, Youth Art Connection. “We have worked together to create a three-panel, hand-painted, portable theatrical backdrop that we look forward to sharing on Monday.” The films, The Viola Vignette and A Long Road to Justice, will also be screened, as will recorded performances from the three finalists of the Music Nova Scotia Viola Desmond Song Writing contest. Nova Scotia Heritage Day falls on the third Monday in February each year. For the next seven years, the Department of Communities, Culture and Heritage will work with communities to commemorate Nova Scotia Heritage Day and recognize its upcoming honourees. For more information, visit http://heritageday.novascotia.ca . FOR BROADCAST USE The North Branch Business Association is hosting the Remembering Viola Community Engagement Forum on Monday (February 16th). It is at the Halifax North Memorial Public Library on Gottingen Street from 10 a-m until 2 p-m. The forum is in honour of Ms. Desmond, the first honouree for Nova Scotia Heritage Day. She was an African Nova Scotian businesswoman wrongfully jailed and fined in 1946 for refusing to give up her seat in the segregated section of a New Glasgow movie theatre. There will be a brainstorming session with Deputy Premier Diana Whalen, Communities, Culture and Heritage Minister Tony Ince and members of the community to develop a legacy piece to Ms. Desmond. A community art project will also be unveiled, there will be film screenings and recorded performances by the three finalists of the Music Nova Scotia Viola Desmond Song Writing contest. For more information visit heritage day dot nova scotia dot c-a. -30-
The American Society of Clinical Oncology (ASCO) is including research by Brock epidemiologist Martin Tammemägi in its review of the most important cancer research conduced in 2014.Tammemägi’s May 28 paper “Impact of lung cancer screening results on smoking cessation,” published in the JNCI: Journal of the National Cancer Institute, “is featured as one of the year’s major achievements in clinical cancer research and care” in Clinical Cancer Advances 2015: ASCO’s Annual Report on Progress Against Cancer, ASCO’s annual review of progress against cancer and emerging trends in the field, says the society(http://cancerprogress.net/sites/cancerprogress.net/files/cca2015_fnl_print2.pdf; see page 13)“It’s a great honour to be recognized by fellow cancer researchers and oncologists,” says Tammemagi. “The American Society of Clinical Oncology is one of the top-ranking cancer oncology organizations in the world.”In that study, Tammemägi and colleagues used data from the U.S. National Lung Screening Trial on 14,621 current smokers, 55 to 70 years old, with a 30 or more pack-a-year smoking history and who had smoked during the last 15 years.For smoking information, the authors used the results of annual study updates starting at one, two, and up to seven years later. Researchers found that the more serious the screening result, the greater the likelihood that smoking stopped. In addition, the effect appeared to be durable, lasting up to five years after the last screening.“People start taking seriously that their health is in danger and they might die,” says Tammemägi of his research’s impact. “Following the abnormal screening they are somewhat shocked into confronting reality. That scare is enough to motivate them into seriously attempting to quit smoking.”Tammemägi is also co-author of another paper that the American Society of Clinical Oncology is including on its list of 2014’s most important cancer research.“Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force,” published March 4 in the Annals of Internal Medicine, used a micro-simulation model to describe the most effective ways of applying Computed Tomography screening for lung cancer in groups of people.That research, conducted by the Cancer Intervention Surveillance Modeling Network (CISMN), enabled the U.S. Preventative Services Task Force to make recommendations in favour of lung screening. Tammemägi is an associate member of the CISNET Lung Group.As of January 2015, under the U.S.’s Affordable Health Care Act, health insurance companies in the US have to pay for the cost of lung screening of qualified individuals between the ages of 55 and 65 years.